Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Harkin

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Neural Regeneration Research|August 15, 2018
Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's diseaseEoin O'Neill, Andrew Harkin
Neuropharmacology|December 23, 2015
Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disordersKatherine O'Farrell, Andrew Harkin
The International Journal of Neuropsychopharmacology|October 5, 2017
Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto RatEoin Sherwin, Aifric Lennon, Andrew Harkin
European Journal of Pharmacology|November 28, 2006
Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administrationRuth McNamara, Mark Maginn, Andrew Harkin
Behavioural Brain Research|August 30, 2016
Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activityEoin Sherwin, Valentina Gigliucci, Andrew Harkin
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 2008
Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in ratsSarah Durkin, Alison Prendergast, Andrew Harkin
Basic & Clinical Pharmacology & Toxicology|December 1, 2004
Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordinationLaura Connole, Andrew Harkin, Mark Maginn
Psychopharmacology|May 4, 2010
Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy')Natacha Vanattou-Saïfoudine, Ruth McNamara, Andrew Harkin
Basic & Clinical Pharmacology & Toxicology|October 5, 2011
Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMANatacha Vanattou-Saïfoudine, Brendan Behan, Andrew Harkin
European Journal of Pharmacology|October 19, 2010
A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine releaseNatacha Vanattou-Saïfoudine, Anna Gossen, Andrew Harkin, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Neural Regeneration Research|August 15, 2018
Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's diseaseEoin O'Neill, Andrew Harkin
Neuropharmacology|December 23, 2015
Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disordersKatherine O'Farrell, Andrew Harkin
The International Journal of Neuropsychopharmacology|October 5, 2017
Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto RatEoin Sherwin, Aifric Lennon, Andrew Harkin
European Journal of Pharmacology|November 28, 2006
Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administrationRuth McNamara, Mark Maginn, Andrew Harkin
Behavioural Brain Research|August 30, 2016
Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activityEoin Sherwin, Valentina Gigliucci, Andrew Harkin
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 2008
Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in ratsSarah Durkin, Alison Prendergast, Andrew Harkin
Basic & Clinical Pharmacology & Toxicology|December 1, 2004
Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordinationLaura Connole, Andrew Harkin, Mark Maginn
Psychopharmacology|May 4, 2010
Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy')Natacha Vanattou-Saïfoudine, Ruth McNamara, Andrew Harkin
Basic & Clinical Pharmacology & Toxicology|October 5, 2011
Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMANatacha Vanattou-Saïfoudine, Brendan Behan, Andrew Harkin
European Journal of Pharmacology|October 19, 2010
A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine releaseNatacha Vanattou-Saïfoudine, Anna Gossen, Andrew Harkin, et al.
Pageof 9